Kristin Yarema

Filings by Kristin Yarema span 3 companies, the busiest being Atara Biotherapeutics, Inc., ImageneBio, Inc. and Poseida Therapeutics, Inc. In total, 14 filings cover trades dated from 1 March 2020 to 14 August 2026.

On the open market, the record shows 3 purchases worth €413k and 1 sale worth €9,058. On balance, insiders were net buyers of €404k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 7 share grants and 1 option exercise.

Half of the purchases are above €42k and half below. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The latest filing, published on 17 August 2026, reports a share grant in ImageneBio, Inc. The latest purchase dates back some time: it was published 1,957 days ago, on 15 June 2021. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.